SC
NVS icon

Sepio Capital’s Novartis NVS Stock Holding History

Sepio Capital’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.15M Buy
13,731
+738
+6% +$111K 0.11% 105
2026
Q1 		$1.98M Sell
12,993
-1,034
-7% -$158K 0.11% 117
2025
Q4 		$1.93M Buy
14,027
+476
+4% +$62.3K 0.11% 118
2025
Q3 		$1.74M Buy
13,551
+356
+3% +$43.4K 0.1% 116
2025
Q2 		$1.6M Buy
13,195
+16
+0.1% +$1.8K 0.11% 117
2025
Q1 		$1.47M Sell
13,179
-489
-4% -$52.1K 0.12% 130
2024
Q4 		$1.33M Sell
13,668
-19
-0.1% -$2.03K 0.11% 140
2024
Q3 		$1.57M Sell
13,687
-133
-1% -$15.1K 0.12% 129
2024
Q2 		$1.47M Sell
13,820
-32
-0.2% -$3.21K 0.13% 126
2024
Q1 		$1.34M Sell
13,852
-1,257
-8% -$129K 0.11% 139
2023
Q4 		$1.53M Sell
15,109
-2,071
-12% -$200K 0.13% 117
2023
Q3 		$1.75M Buy
17,180
+939
+6% +$95.3K 0.15% 115
2023
Q2 		$1.64M Sell
16,241
-649
-4% -$64.9K 0.13% 154
2023
Q1 		$1.55M Sell
16,890
-17,250
-51% -$1.51M 0.14% 154
2022
Q4 		$3.1M Sell
34,140
-12,208
-26% -$1.03M 0.27% 101
2022
Q3 		$3.52M Sell
46,348
-2,751
-6% -$228K 0.35% 91
2022
Q2 		$4.15M Sell
49,099
-2,870
-6% -$252K 0.42% 74
2022
Q1 		$4.56M Sell
51,969
-5,703
-10% -$494K 0.4% 82
2021
Q4 		$5.04M Sell
57,672
-1,199
-2% -$99.6K 0.37% 74
2021
Q3 		$4.81M Buy
58,871
+689
+1% +$62K 0.4% 64
2021
Q2 		$5.31M Sell
58,182
-1,463
-2% -$130K 0.44% 56
2021
Q1 		$5.1M Buy
+59,645
New +$5.35M 0.47% 52
2019
Q3 		– Sell
-24,437
Closed -$2.23M – 270
2019
Q2 		$2.23M Sell
24,437
-3,034
-11% -$257K 0.3% 91
2019
Q1 		$2.37M Sell
27,471
-3,590
-12% -$288K 0.32% 88
2018
Q4 		$2.39M Buy
+31,061
New +$2.42M 0.17% 101

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Sepio Capital's NVS Position: Q2 2026 in Review

Sepio Capital increased its Novartis (NVS) stake by 5.7% in Q2 2026, buying an estimated $111K and bringing the position to 13,731 shares worth $2.15M. The position accounts for 0.11% of the portfolio, ranked #105.

Sepio Capital first reported a position in NVS in Q4 2018 and has held it in 25 quarters since. The position peaked at $5.31M in Q2 2021. 1,623 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Sepio Capital held 13,731 shares of Novartis worth $2.15M as of Q2 2026.
  • Sepio Capital bought 738 Novartis shares in Q2 2026, an estimated $111K.
  • Novartis made up 0.11% of Sepio Capital's portfolio in Q2 2026, its #105 holding.
  • Sepio Capital first reported a position in Novartis in Q4 2018 and has held it in 25 quarters since.
  • Sepio Capital's Novartis position peaked at $5.31M in Q2 2021.
  • 1,623 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Sepio Capital's 13F filing for Q2 2026, filed 28 Jul 2026.